SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-22-004015
Filing Date
2022-03-21
Accepted
2022-03-21 17:16:03
Documents
85
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tmb-20211231x10k.htm   iXBRL 10-K 1782109
2 EX-21.1 tmb-20211231xex21d1.htm EX-21.1 3477
3 EX-23.1 tmb-20211231xex23d1.htm EX-23.1 13760
4 EX-31.1 tmb-20211231xex31d1.htm EX-31.1 14341
5 EX-31.2 tmb-20211231xex31d2.htm EX-31.2 14532
6 EX-32.1 tmb-20211231xex32d1.htm EX-32.1 7067
7 EX-32.2 tmb-20211231xex32d2.htm EX-32.2 7012
  Complete submission text file 0001558370-22-004015.txt   7954305

Data Files

Seq Description Document Type Size
8 EX-101.SCH tmb-20211231.xsd EX-101.SCH 59182
9 EX-101.CAL tmb-20211231_cal.xml EX-101.CAL 53914
10 EX-101.DEF tmb-20211231_def.xml EX-101.DEF 234329
11 EX-101.LAB tmb-20211231_lab.xml EX-101.LAB 510560
12 EX-101.PRE tmb-20211231_pre.xml EX-101.PRE 416384
79 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20211231x10k_htm.xml XML 1309393
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36020 | Film No.: 22756386
SIC: 2834 Pharmaceutical Preparations